There is growing evidence that modulation of BDNF expression levels can exert antidepressant effects (46–48), where BDNF-cAMP response element binding protein (CREB) signaling is one of the most attractive signaling pathways for the treatment of depression (49, 50). The gene discussed is BDNF; the disease is depressive symptom measurement.